SNDX
SNDX
NASDAQ · Biotechnology

Syndax Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$20.40
+0.64 (+3.24%)
As of Aug 8, 10:05 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 19 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +20.0% upside
Low Target $15.15
Average Target $24.49
High Target $32.88
Current Price $20.40
Current
$20.40
Target
$24.49
$15.15 $24.49 avg $32.88
Scenario Analysis
Bear Case
$15.15
-25.7%
Low target
Base Case
$24.49
+20.0%
Avg target
Bull Case
$32.88
+61.2%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$25.59
-20.3% from high
52-Week Low
$12.10
+68.6% from low
Target vs 52W High
$24.49
-4.3% vs high
Next Earnings Report
Aug 10, 2026
1d
tomorrow
EPS Est: $-0.45
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 44 64% $91.45 -56.0%